310455-02-8 Usage
General Description
3-Piperidinecarboxamide, N, N-dimethyl, (3S)-(9CI) is a chemical compound with the molecular formula C8H16N2O. It is a derivative of piperidine, a heterocyclic amine, and contains a carboxamide group. The (3S)-(9CI) designation indicates the stereochemistry of the molecule. 3-Piperidinecarboxamide,N,N-dimethyl-,(3S)-(9CI) is commonly used in organic synthesis and pharmaceutical research as a building block for various drugs and bioactive molecules. It has potential applications in the development of new drugs and therapeutic agents due to its pharmacological properties and ability to modulate biological processes. Additionally, this compound may also have potential uses in the agrochemical industry for the development of new pesticides or herbicides.
Check Digit Verification of cas no
The CAS Registry Mumber 310455-02-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,0,4,5 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 310455-02:
(8*3)+(7*1)+(6*0)+(5*4)+(4*5)+(3*5)+(2*0)+(1*2)=88
88 % 10 = 8
So 310455-02-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H16N2O/c1-10(2)8(11)7-4-3-5-9-6-7/h7,9H,3-6H2,1-2H3/t7-/m0/s1
310455-02-8Relevant articles and documents
Efficient asymmetric hydrogenation of pyridines
Glorius, Frank,Spielkamp, Nick,Holle, Sigrid,Goddard, Richard,Lehmann, Christian W.
, p. 2850 - 2852 (2007/10/03)
Up to four stereocenters can be created efficiently in a single step by the asymmetric hydrogenation of oxazolidinone-substituted pyridines (see scheme). Furthermore, selective chirality transfer and nondestructive cleavage of the chiral auxiliary occur under the same reaction conditions, making an additional cleavage step unnecessary.
Immunopotentiator agents
-
Page column 23, (2010/02/05)
Novel compounds and methods for preparing same, immunopotentiating compositions, and a method for potentiating the immune system of a host animal. The method comprises administering to the animal an effective amount of an immunopotentiating compound of Formula I or Formula II, or a physiologically acceptable salt.